Lawrence Evans

Title: The Innovative Contributions of Lawrence Evans

Introduction

Lawrence Evans is a prominent inventor based in Seattle, WA, known for his significant contributions to the field of immunology. With a total of seven patents to his name, Evans has made remarkable strides in developing immunomodulatory proteins that have therapeutic applications for various diseases.

Latest Patents

Among his latest patents is the development of CTLA-4 variant immunomodulatory proteins and their uses. This patent provides variant CTLA-4 polypeptides and immunomodulatory proteins, along with nucleic acids encoding such proteins. These immunomodulatory proteins are designed to offer therapeutic utility for a range of disease applications, particularly in treating autoimmune or inflammatory conditions. Another notable patent involves April and BAFF inhibitory immunomodulatory proteins and methods of use. This patent details immunomodulatory proteins that exhibit neutralizing activity of BAFF and APRIL, including TACI-Fc fusion proteins. The therapeutic utility of these proteins extends to various immunological diseases, disorders, or conditions.

Career Highlights

Lawrence Evans has worked with several notable companies throughout his career, including Alpine Immune Sciences, Inc. and Corixa Corporation. His work in these organizations has contributed to advancements in immunotherapy and the development of innovative treatments.

Collaborations

Evans has collaborated with esteemed colleagues such as Joseph Leon Kuijper and Ryan Swanson, further enhancing the impact of his research and inventions.

Conclusion

Lawrence Evans stands out as a key figure in the field of immunology, with his innovative patents and collaborations paving the way for new therapeutic approaches. His work continues to influence the development of treatments for autoimmune and immunological conditions.